We also found that a poor prognosis and relapse in stage III colon cancer patients could be predicted by the circulating GPC1+ exosomes, or the regulatory microRNA of GPC1 (miR-96-5p and miR-149). This evidence concerns the gene GPC1 and malignant colon neoplasm.